High purity 99% factory price in stock Remdesivir powder

High purity 99% factory price in stock Remdesivir powder

Min.Order / FOB Price:Get Latest Price

1 Kilogram	FOB Price:USD 15.0000 -500.0000

1 Kilogram

FOB Price:USD 15.0000 -500.0000

Min.Order :1 Kilogram
Purity: 99% up
Payment Terms : L/C,D/A,D/P,T/T,,MoneyGram,Other

Keywords

Remdesivir factory price High purity 99%

Quick Details

Appearance:White powder
Application: It can synthesize antivirals by inhibiting viral nucleic acids. A clinical Chemicalbook bed study for infection is currently in phase II.
PackAge:1kg/bag ;5kg/drum:25KG/drum
ProductionCapacity:20|Metric Ton|Month
Storage:in low tempreture
Transportation:In well-closed container, protected from light and in cool & dry place.

Superiority:

Why is SINOWAY:

1) Specialized in pharmaceutical and healthcare industrial for 34 years.

2) ISO 9001:2015 & SGS audited supplier .

3) Accept various payment terms : T.T 30-60 days.

4) We have warehouse in USA with quickly shipment .

5) We can do different terms of FOB ,CIF/CIP ,DDP ...

Why choose us

1. best quality in your requirement
2. competitive price in china market
3. mature technical support
4. professional logistic support
5. full experience of large numbers containers loading in chinese sea port
6. fast shipment by reputed shipping line
7. packing with pallet as buyer's special request
8. best service after shipment with email !
9. cargoes together with container after-sales service available
10. full experience in export
11. raw materials from chinese origin

Details:

Product Information

Product Name	Re-mdesivir
CAS	1809249-37-3
Molecular formula	C27H35N6O8P
Molecular weight	602.58
Grade	Pharmaceutical Grade
Color	White powder
Purity	99%
Shelf life	2 years

Usage

Remdesivir is a nucleoside analogue and is an RNA-dependent RNA polymerase (RdRp) inhibitor. It can synthesize antivirals by inhibiting viral nucleic acids. A clinical Chemicalbook bed study for infection is currently in phase II. MERS-infected mice performed much better with this combination therapy, with reduced virus replication and improved lung function. Recent studies have shown that Radixivir has a certain activity in inhibiting the new crown virus